Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12% Market Closed
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Cost of Revenue Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Cost of Revenue
-NT$194.1m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
-4%
G
Grape King Bio Ltd
TWSE:1707
Cost of Revenue
-NT$2.4B
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
-13%
Maywufa Co Ltd
TWSE:1731
Cost of Revenue
-NT$483.5m
CAGR 3-Years
-5%
CAGR 5-Years
0%
CAGR 10-Years
3%
Chlitina Holding Ltd
TWSE:4137
Cost of Revenue
-NT$731.1m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
-1%

See Also

What is Maxigen Biotech Inc's Cost of Revenue?
Cost of Revenue
-194.1m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Cost of Revenue amounts to -194.1m TWD.

What is Maxigen Biotech Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%

Over the last year, the Cost of Revenue growth was 8%. The average annual Cost of Revenue growth rates for Maxigen Biotech Inc have been 6% over the past three years , 3% over the past five years , and -4% over the past ten years .

Back to Top